Medicare s s 2009 eprescribing Program

Similar documents
PCC EHR eprescribing Best Practices

The Real-Time Benefit Check Key to Closing the Gaps in Eligibility Driven Formulary. Tony Schueth Chief Executive Officer & Managing Partner

Employers Forum of Indiana and epa. March 23, 2016

NCVHS. May 15, Dear Madam Secretary,

Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]

January 16, Submitted electronically via:

erx Tips and Tricks Lauren Gluck User's Conference 2015

Project: Surescripts Prescriptions Benefits - Eligibility & Formulary

Real-Time Pharmacy Benefit Inquiry: The Time is Right for More Informed Medication Decisions

SecurityBlue HMO. Link to Specific Guidance Regarding Exceptions and Appeals

Martin s Point Generations Advantage Policy and Procedure Form

BlueRx PDP. Link to Specific Guidance Regarding Exceptions and Appeals

Payment Adjustments & Hardship Exceptions Tipsheet for Eligible Professionals Last Updated: August, 2012

MEDEHR Certified Version 2.0 New Feature

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:

National Provider Call:

RELIEF FOR ELIGIBLE PROFESSIONALS? PROPOSED STAGE 2 MEANINGFUL USE RULE INCLUDES IMPORTANT (POTENTIAL) EXCEPTIONS [OBER KALER]

2019 Transition Policy

2018 Medicare Part D Transition Policy

Electronic Prior Authorization Initiatives at the Point of Care: Moving the Industry Forward

[F5] Leveraging Technology for Patient- Level Formulary & Benefit Information at the Point of Care

Extra Time to Succeed in Meaningful Use, A New CMS FAQ Confirms

PURPOSE OF THE POLICY STATEMENT OF THE POLICY PROCEDURES

Medicare Part D Transition Policy

The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use. Presented by Daniel Tomaszewski Pharmd, PhD

Medicare Part D Transition Policy CY 2018 HCSC Medicare Part D

Update on Medicare s Physician Incentive Programs

2019 Transition Policy and Procedure

Medicare Transition POLICY AND PROCEDURES

Contract Summary. OptumRx Administrative Services, LLC

A Guide to Healthcare Buzzwords and What They Mean: Part One (A through L)

There is nothing wrong with change, if it is in the right direction Winston Churchil

Y0076_ALL Trans Pol

REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax:

HIPAA Readiness Disclosure Statement

Automating Specialty Pharmacy: Identifying Gaps

Formulary Services EULA

Regulatory/Legislative Update

2012 Medicare Physician Fee Schedule Final Rule Summary

E-PRESCRIBING SERVICES TERMS

All Medicare Advantage Products with Part D Benefits

Best Practice Recommendation for

Compliance Program. Health First Health Plans Medicare Parts C & D Training

Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - Pharmacy

REPORT 8 OF THE COUNCIL ON MEDICAL SERVICE (I-11) Administrative Simplification in the Physician Practice (Reference Committee J) EXECUTIVE SUMMARY

Update: Electronic Transactions, HIPAA, and Medicare Reimbursement

Track III-A. Creating Relationships with Prescription Drug Plans and Managed Care Organizations

Jill Rosenthal, MD, MA, MPH, FACOEM SVP, Chief Medical Officer Zenith Insurance Company

Classification: Clinical Department Policy Number: Subject: Medicare Part D General Transition

Contract Summary. OptumRx Administrative Services, LLC

Values Accountability Integrity Service Excellence Innovation Collaboration

Contract Pharmacy Relationships

Compliance and Fraud, Waste, and Abuse Awareness Training. First Tier, Downstream, and Related Entities

Medicare Advantage Part D Pharmacy Policy

Current Status Of Legislation on Quality Bench Marks

PRESCRIPTION MONITORING PROGRAM MODEL ACT

REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax:

APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1

Texas Vendor Drug Program. Drug Addition Process. Effective Date. December 2017

Implement a definition of negotiated price to include all pharmacy price concessions.

Center for Medicaid and State Operations. March 22, 2007 SMDL # Dear State Medicaid Director:

Information Maintained by the Office of Code Revision Indiana Legislative Services Agency IC Chapter 22. Pharmacy Audits

Summary of 2017 Medicare Part D Final Call Letter

MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE. Reporting Requirements: Audit Preparedness for PDPs and Manufacturers

HIPAA Electronic Transactions & Code Sets

THIRD PARTY REIMBURSEMENT OF COVERED ENTITIES: MANUFACTURERS PERSPECTIVE

TRANSITION POLICY. Members Health Insurance Company

Texas Vendor Drug Program Pharmacy Provider Procedure Manual

Important Information about our prescription drug program

2012 Checklist for Community Pharmacy. Medicare Part D-Related Information

Glossary. Last Reviewed 11/10/14

Medicare Prescription Drug, Improvement and Modernization Act

21 - Pharmacy Services

Sender's Direct Phone (202) Sender's Direct Facsimile (202) MEMORANDUM

Glossary of Terms (Terms are listed in Alphabetical Order)

The Impact of Standards & Pharmacy Informatics

Highlights from the proposed rule include the following:

Subject: Indiana Health Coverage Programs (IHCP) Transition to the National Council for Prescription Drug Programs (NCPDP) Version 5.

Chapter 10 Prescriptions Benefits and Drug Formulary

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training. Developed by the Centers for Medicare & Medicaid Services

eprescribing s Formulary and Benefits: At a Crossroad By Tony Schueth, Editor-in-Chief

Payment Adjustments & Hardship Exceptions for Eligible Hospitals and CAHs Last Updated: March 2014

June 25, Seema Verma Administrator Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

NCPDP Update. Review of NCPDP Task Group Efforts and Use Cases for Real-Time Benefit Inquiry Standard. May 23, 2017

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training

MEDICARE PLAN PAYMENT GROUP

Community Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018

APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1

APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1

April 8, Dear Mr. Levinson,

DMHC Update CAHP Conference 2017

January 25, Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Outof-Pocket Expenses [CMS 4180 P] RIN 0938 AT92

Advanced Endocrinology and Weight Management Ritu Malik MD

Legislative Update HIPAA/HITECH

Introduction Presentation: Elizabeth W. Woodcock, MBA, FACMPE, CPC Kareo Special Offer: Matt Kelly, Account Executive, Kareo Questions

EGWP Frequently Asked Questions For SSC & USG Benefits Administrators

1 Security 101 for Covered Entities

The benefits of electronic claims submission improve practice efficiencies

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual. Managed Care. Effective Date. November 2017

Provider Insider January 2017

Transcription:

Medicare s s 2009 eprescribing Program Daniel Green, MD, FACOG Medical Officer, Quality Measurement Health Assessment Group Office of Clinical Standards and Quality Centers for Medicare & Medicaid Services Baltimore, MD

Overview Review MIPPA provisions relevant to new eprescribing incentive. Review eprescribing measure in 2008 PQRI Review implementation schedule for 2009 PQRI and eprescribing incentive.

MIPPA Legislation PQRI The Medicare Improvements for Patients and Providers Act (MIPPA), passed in July 2008, contains several new authorities and requirements for quality reporting and PQRI for 2009 and beyond. Section 132 contains the new electronic prescribing incentive provisions.

MIPPA Legislation Successful Electronic Prescriber, Section 132 The MIPPA provides for a 2% incentive payment to eligible professionals who successfully prescribe (as defined by the statute) their patient s medications electronically beginning in 2009. The legislation specifically refers to applicable electronic prescribing quality measures (i.e., eprescribing measure #125).

MIPPA Legislation Successful Electronic Prescriber, Section 132 (cont) eprescribing measure will be removed from PQRI for 2009 and added to the eprescribing incentive program. The Secretary has the authority to update the specifications of the electronic prescribing measure in the future.

2008 PQRI eprescribing Measure Electronic Prescribing Structural Measure (measure #125) qualifies as one of three required measures in PQRI to earn an incentive payment. Requirement for 2008 PQRI is to report the measure on 80% or more of eligible patients. No separate incentive for successful eprescribing in 2008 PQRI.

Electronic Prescribing Measure in 2008 PQRI If you have not adopted an electronic prescribing system that meets the specifications of the measure, you cannot report on this measure. The measure is intended to be reported for EVERY patient visit in the denominator.

Qualified Electronic Prescribing Systems Measure #125 The measure assesses an eligible professional s use of electronic prescribing using a qualified system. As a qualified system, the program must be able to perform the following tasks: Generate a medication list incorporating electronic data received from pharmacies or PBMs (if available) Select medications Transmit prescriptions electronically and conduct safety alerts

Qualified Electronic Prescribing Systems Measure #125 (cont) Conduct safety alerts Automated prompts that offer information on the drug being prescribed Potential inappropriate dose or route of administration of the drug, drug-drug interactions Allergy concerns Warnings and cautions Provide information on lower cost alternatives (if any). (Tiered formulary information, if available, would satisfy this requirement for 2009) Provide information on formulary or tiered formulary medications, patient eligibility and authorization requirements received electronically from the patient s drug plan (if available).

Additional erx System Requirements The System must employ the current Part D standards for the functionalities they provide

Part D Standards The standards refer to the version of messaging that the eprescribing program uses to send the information over the prescription network. It is similar to an update of a particular software product (i.e. Word 97 vs. Word 2003).

How eprescribing Works An eligible professional decides to order a prescription for a patient. The prescription is entered into an eprescribing program and is transmitted to the desired pharmacy. Communication also occurs between the pharmacy benefit manager and the physician.

eprescribing Communication Professional PBM Pharmacy

SureScripts-RxHub Network where the prescription communication or messaging travels between the 3 entities involved in eprescribing (i.e., the professional, pharmacy and PBM). Approximately 90% of US prescriptions use the SureScripts-RxHub network. eprescribing vendors using the SureScripts- RxHub network must be certified by SureScripts-RxHub.

Determining if your System is Part D Compliant Vendors listed on the SureScripts website, www.surescripts.com/getconnected.aspx?ptype=physician, meet the 2009 Part D standards for the functions they provide.

Qualified eprescribing Systems for 2009 If an eprescribing system is not on the SureScripts network, a potential customer should look at the Part D standards on the CMS website and check with the product s vendor. You must HAVE and USE a qualified eprescribing system. If purchasing a system, have the vendor demonstrate each functionality described in the measure

Earning 2% Through eprescribing Patient must have an encounter with one of these CPT or G-codes: 90801, 90802, 90804, 90805, 90806, 90807, 90808, 90809, 92002, 92004, 92012, 92014, 96150, 96151, 96152, 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99241, 99242, 99243, 99244, 99245, 99381, 99382, 99383, 99384, 99385, 99386, 99387, 99391, 99392, 99393, 99394, 99395, 99396, 99397, G0101, G0108, G0109

Earning 2% Through eprescribing Report on all eligible patients to ensure success. 3 G-codes can be used in this measure: G8443 G8445 G8446

eprescribing G-codes G8443 All prescriptions created during the encounter were generated using a qualified e-prescribing system. OR G8445 No prescriptions were generated during the encounter. Provider does have access to a qualified e-prescribing system. OR G8446 Provider does have access to a qualified eprescribing system. Some or all prescriptions generated during the encounter were printed or phoned in as required by state or federal law or regulations, patient request or pharmacy system being unable to receive electronic transmission; OR because they were for narcotics or other controlled substances.

Measure #125 for 2009 eprescribing The Secretary may change the measure specifications until December 31, 2008

Additional Information CMS has an eprescribing section page on the PQRI website at www.cms.hhs.gov/pqri This section will contain information on: The MIPPA legislation A fact sheet describing the MIPPA eprescribing incentive provisions Part D standards eprescribing Made Simple Other documents/instructions

CCHIT CCHIT currently certifies EHRs which contain eprescribing modules. 2008 CCHIT certified systems meet the functionality requirements of the measure Some of the erx modules may be available for purchase separately.

CCHIT (cont) Some products are designated partners of 2008 CCHIT certified EHRs. These partners would meet the functionality requirements CCHIT expects to review stand-alone systems for certification starting in mid-2009.

Reporting of the eprescribing Measure as Described Under the MIPPA Statute Successful reporting is defined as reporting the measure on at least 50% of eligible patients. Limitation: CPT codes that make up the denominator of the erx measure MUST account for at least 10% of the provider s total allowed charges for Medicare Part B covered services during the reporting period.

Incentives for Successful eprescribing Under MIPPA A 2% payment incentive for successful use of eprescribing is available for 2009 & 2010. In 2011 and 2012 the payment incentive drops to 1% of covered Medicare Part B charges. In 2013 the incentive drops to 0.5% of the covered Medicare Part B charges.

Future Penalties for Not Electronically Prescribing Eligible professionals who are not successfully using electronic prescribing by 2012 will be penalized 1% of their covered Medicare Part B charges. This means that these providers will be paid at 99% for their covered Medicare Part B fee schedule services.

Future Penalties for Not Electronically Prescribing (cont) Fee reduction is prospective, providers will have to electronically prescribe by a date to be determined to be sure their fees are not reduced in 2012. This date will not be before 2010. Hardship exemption.

Future Penalties for Not Electronically Prescribing (cont) In 2013 1.5% deducted from their covered Medicare Part B services. Professionals will be paid at 98.5% of the physician fee schedule for covered services. In 2014 and beyond penalty will increase to 2%. Professionals will receive 98% of the physician fee schedule for the covered services they provide.

Part D Information The Secretary has the authority to change the requirements for successful eprescribing in the future. The MIPPA legislation allows for future use of Part D data (i.e., a specific number of electronically written prescriptions) in lieu of claims-based reporting by eligible professionals.

Implementation Schedule for 2009 PQRI and eprescribing Incentive 2009 PQRI 2009 PFS Rule posted July 1, 2008; comment period for proposed rule ended 8/29/08. MIPPA provisions enacted July 15, 2008. 2009 Electronic Prescribing Incentive Details of the program were Published in the Physician Fee Schedule Final Rule section of the Federal Register in November, 2008

Additional PQRI Resources For more information on PQRI and eprescribing, please visit our website at: www.cms.hhs.gov/pqri Thank you!